Advanced Enzyme Technologies (NSE)
Advanced Enzyme Technologies Limited (Индия) производит ферменты и пробиотики и разрабатывает их применение. Клиенты — фармацевтика, нутрицевтика, ветеринария, хлебопечение, растениеводство, переработка отходов, текстильная и кожевенная промышленность, производство спирта, переработка зерна, пивоварение, производство соков. Цель компании — заменять ферментами и пробиотиками агрессивные лекарства и …
Профиль
Advanced Enzyme Technologies Limited (AETL; NSE: ADVENZYMES, BSE: 540025) is a research-driven specialty biotech company that R&D, manufactures, and markets enzymes and probiotics used across human nutrition, animal nutrition, baking, and bio-processing industries, aiming to replace chemical processes with eco-safe enzymatic solutions. Incorporated in 1989; registered office in Thane, Maharashtra, India (corporate office also in Thane). Core products: enzymes and probiotics (100% of turnover in FY25-26). Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies. Scale: FY26 standalone turnover ₹4,527.66m; employees ~400 (as of FY25-26 end); exports are 33.58% of revenues; PAN-India presence and exports to 52 countries; 4 plants, 2 offices in India; 2 R&D labs; ~500+ employees/750+ employees figures also cited in materials. Ownership/listing/investors: listed on BSE and NSE since Aug 2016; shareholders include public and notable funds like Nalanda India Equity Fund, Orbimed Asia, Cl arus Capital, Marval Capital, Polunin Capital (examples shown). Funding: no specific 2025-26 funding disclosed in results; historical note mentions Kotak Private Equity investment and equity/IPO-related milestones, but not new funding for 2025-26. Key customers/partners: sells proprietary enzymes & probiotics and customized solutions to human nutrition, animal nutrition, and bio-processing industry customers; 700+ customers worldwide and >400 proprietary products; customers across 45+ countries. Latest 2025-26 developments and active status: FY2025-26 BRSR and FY26 earnings/annual reporting were published, with consolidated revenue from operations ₹7,458m (FY26), and the company remains active in 2025-26 reporting. In FY25-26 it also approved and incorporated a new subsidiary, Advanced Nutrazyme Private Limited (incorporated 4 July 2025).
Sources#
- Отрасль
- Энергетика, Оборудование для биопроизводства, Корма, Пищевые ингредиенты, Промышленная химия, Текстиль и кожа, Ветеринария
- Темы
- Ферменты и биокатализ, Пробиотики и закваски, Корма и кормовые добавки, Витамины, каротиноиды и активные вещества нутрицевтиков
- Роль
- Производитель — “…y biotech company that R&D, manufactures, and markets enzymes and probiotics used across human nutrition, anim…”
Биорешения, которые поставляет 3
Проверенные совпадения продуктов: bioscouring → T02; Laccase and peroxidase → T02, T03; Cool type amylases → T02; replace chemicals or processes that present safety → I07, I02;
Что предлагают
Сертификаты: ISO 22000:2005; ISO 9001:2008; WHO cGMP; ISO 9001:2015; Indonesian Halal; SSS Europe; FSSC 22000; GMP; Star Export House; ISO Certified Company
- Сертификаты (сайт)
- ISO 22000:2005 · ISO 9001:2008 · WHO cGMP · ISO 9001:2015 · Indonesian Halal · SSS Europe · FSSC 22000 · GMP · Star Export House · ISO Certified Company · GMP Plus · IRQS
- Клиенты и партнёры
- 700 customers across 45 countries worldwide · three wholly owned subsidiaries · three joint ventures · five stepdown subsidiaries · over 40 Countries · Evoxx Technologies GmbH
- Производственные площадки
- India — Enzymes and Probiotics · U.S. — Enzymes and Probiotics · Europe — Enzymes and Probiotics · Pitampur SEZ, District Dhar, Madhya Pradesh, India · Sinnar, District Nashik, Maharashtra, India · Vashind, District Thane, Maharashtra, India — over 2000 metric tons of feed ingredients annually · Satpur, District Nashik, Maharashtra, India — 36 metric tons per annum · Chino, California, United States · Thane (W) 400 604, India · Chino, CA 91710 · Monheim am Rhein, Germany
- Научные центры (R&D)
- Process Development Lab · Applied Microbiology Lab · Life Sciences Application Lab · Food Applications Development Lab · Industrial Applications Development Lab
Прочитано на сайте компании: about · products · production · quality · rnd · leadership · contact · topic
Дочерние компании: Advanced Bio-Agro Tech Limited · Enzytech Advanced Solutions Limited · Enzymes Advanced (‘AEU’) USA, Inc. · Advanced Supplementary Technologies Corporation · Cal India International Foods (CAL) · Enzyme Innovation, Inc · Starya Labs, Inc. · JC Biotech Private Limited · Scitech Specialities Private Limited · Advanced Enzymes Europe B.V. (AEEBV) · Evoxx Technologies GmbH · Saiganesh Enzytech Solutions Private Limited
Бизнес-модель · enzymes
Advanced Enzyme Technologies Ltd is a research-driven company that manufactures and markets a wide range of enzymes and probiotics for industries including human nutrition, animal nutrition, and bio-processing. It provides proprietary products and customized solutions to over 700 clients across more than 45 countries. The company earns revenue through the sale of these performance ingredients, often pricing based on the value created for customers through its specialized technical know-how and R&D capabilities.
| Enzymes and Probiotics FY26 The company's consolidated revenue for FY26 was 7,458 million INR, with a consolidated EBITDA margin of 31%. “Revenue from operations rose 17% to ₹7,458 million from ₹6,369 million in FY25... EBITDA (excl. other income): ₹2,291 million (31%)” | scanx.trade weak (company, news, market research, other) |
| FY26 Consolidated R&D expenditure for FY26 was 246 million INR, representing 3.30% of net sales. “Consolidated R&D expenditure for FY26 was ₹246 million (3.30% of net sales), compared to ₹248 million (3.86% of net sales) in FY25.” | scanx.trade weak (company, news, market research, other) |
| 1989 Advanced Enzyme was incorporated in 1989 by Mr V L Rathi and Mr C L Rathi as Advanced Biochemicals Pvt Ltd and was renamed in 2005. “Advanced Enzyme was incorporated in 1989 by Mr V L Rathi and Mr C L Rathi as Advanced Biochemicals Pvt Ltd; it was renamed in 2005.” | www.crisil.com weak (company, news, market research, other) |
The company operates in a highly volatile industry where R&D risks include cost escalation due to elongated timelines and potential lower ROI from delayed product launches. “Risk The Company operates in highly volatile & evolving industry that needs continuos and efficient R&D. Many a times R&D takes more than expected time & resources, leading to the cost escalation. At times, despite …” | www.advancedenzymes.com weak (company, news, market research, other) |
| Enzymes and probiotics Enzymes can often replace chemicals or processes that present safety or environmental issues. “Developed Enzymes and probiotics. Enzymes can often replace chemicals or processes that present safety or environmental issues.” | www.advancedenzymes.com weak (company, news, market research, other) |
| ADDSCOUR (Alkaline pectinase) The use of alkaline pectinase for bioscouring of cotton reduces environmental impact and is often more economical than conventional chemical scouring. “The use of an alkaline pectinase reduces the environmental impact, and in most cases, works out to be more economical.” | advancedenzymes.com weak (company, news, market research, other) |
| Alkaline pectinase (Biopreparation process) Biopreparation using alkaline pectinase allows for a reduction in rinsing water by more than half compared to traditional processes, saving significant energy. “It has been welcomed because rinsing water can be reduced by more than half compared to the traditional processes.” | advancedenzymes.com weak (company, news, market research, other) |
| Laccase and peroxidase (e.g., INDIGO WASH, INDIGO WASH Laccase) Laccase and peroxidase enzymes are used to create an aged look on denim while replacing bleaching chemicals. “Laccase and different types of peroxidase helped meet this giving a novel finish to need, being very effective for denim while replacing bleaching chemicals.” | advancedenzymes.com weak (company, news, market research, other) |
| COOL TYPE AMYLASES and COOL TYPE CELLULASES (e.g., RAPIDENZ COOL) Cool type amylases and cellulases enable a completely cool process for denim garment processing, which saves energy. “For denim garment processing, Advanced Enzymes offers a completely cool process. This is achieved with COOL TYPE AMYLASES and COOL TYPE CELLULASES.” | advancedenzymes.com weak (company, news, market research, other) |
Новости и статус 6
- 2026-08 Последний статус: В августе 2026 г. компания начала обратный выкуп акций на открытом рынке, а в 2026 г. выкупила оставшуюся долю в дочерней JC Biotech. ↗ ↗ ↗
- 2026-08-08 Advanced Enzymes Q1 results: Profit, EBITDA slips, company announces share buyback - CNBC TV18Advanced Enzyme Technologies posted a Q1 FY27 profit of ₹37 crore (down 7.5% YoY) with revenue up 2.2% to ₹190 crore and EBITDA down 9.6% to ₹51.1 crore, margins sliding to 26.9%. The board approved a buyback of up to ₹697 million at a maximum ₹500 per share …
- 2026-08-20 Advanced Enzyme Consolidated June 2026 Net Sales at Rs 189.79 crore, up 2.08% Y-o-Y- Moneycontrol.comAdvanced Enzyme Technologies posted June 2026 consolidated net sales of Rs 189.79 crore, up 2.08% year-on-year, but net profit declined to Rs 37.09 crore (down 7.1% YoY) and EPS fell to Rs 3.31. Revenue was lower than the previous quarter’s Rs 203.37 crore, …
- 2026-09-21 Advanced Enzyme Tech buys 50,000 shares on Sep 21 at avg ₹289.49Advanced Enzyme Technologies is steadily progressing with its open market buyback, having purchased 50,000 shares at an average ₹289.49 on Sep 21, 2026, bringing total bought-back to 14,58,904 shares, well within its defined buyback size and timetable. The …
- 2026-09-08 Advanced Enzyme Technologies extinguishes 8.25 lakh shares bought backAdvanced Enzyme Technologies extinguished 8,25,028 equity shares bought back in August 2026 via open market, processed by CDSL on Sep 2, 2026, in dematerialized form, under SEBI Buy-Back Regulations 2018. The company also reported a Q1FY27 PAT decline to ₹386 …
- 2026-08-08 Advanced Enzyme Technologies consolidated net profit declines 7.11% in the June 2026 quarter| Capital Market NewsAdvanced Enzyme Technologies’ June 2026 quarter shows a decline in net profit by 7.11% to Rs 37.09 crore, despite sales rising 2.09% to Rs 189.79 crore. Operating margin decreased (OPM from 30.35% to 26.86%), with both PBDT and PBT dipping slightly.
- 2026-08-08 Advanced Enzyme Technologies Reports Q1 FY27 Results: Revenue at 1,898 Million INR, PAT Grows 30% Y-o-YAdvanced Enzyme Technologies reported Q1 FY27 revenue of ₹1,898 million with PAT ₹386 million, marking a 2% year‑over‑year revenue rise but a 5% decline in PAT; EBITDA margin eased to 27% (down from 30–31%), and EPS fell to ₹3.31. The company remains focused …
Связи: владельцы, партнёры, аналоги
Владельцы и инвесторы 13
| дочерняя | Advanced Bio-Agro Tech Limited |
| дочерняя | Enzytech Advanced Solutions Limited |
| дочерняя | Enzymes Advanced |
| дочерняя | Advanced Supplementary Technologies Corporation |
| дочерняя | Cal India International Foods |
| дочерняя | Enzyme Innovation, Inc |
| дочерняя | Starya Labs, Inc |
| дочерняя | JC Biotech Private Limited |
| дочерняя | Scitech Specialities Private Limited |
| дочерняя | Advanced Enzymes Europe B.V |
| дочерняя | Evoxx Technologies GmbH |
| дочерняя | Saiganesh Enzytech Solutions Private Limited |
| дочерняя | Advanced Nutrazyme Private Limited |
Партнёры и сделки 2
| сторона сделки | JC Biotech Private Limited (acquired remaining 4.28% stake) …The company initiated an open market buyback of its equity shares in August 2026 and completed the acquisition of the remaining stake in its subsidiary, JC Biotech, in 2026.… |
| совместное предприятие | Evoxx Technologies GmbH ( …customers across 45 countries worldwide ( )
- three wholly owned subsidiaries ( )
- three joint ventures ( )
- five stepdown subsidiaries ( )
- over 40 Countries ( )
- Evoxx Technologies GmbH (… |
Похожие компании
S.I. Biozyme · Amano Enzyme · Qingdao Vland Biotech Group Co., Ltd. · KDN Biotech (SHANGHAI) CO., LTD · Sanzyme Biologics · Sunson Industry Group Co., Ltd · XIKE Enzymes · Enzyme Bioscience Pvt Ltd
Реквизиты и контакты
Контакты, руководители и юридические данные доступны участникам.
Войти как участник